These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29718992)

  • 1. Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012.
    Mak D; Babb de Villiers C; Chasela C; Urban MI; Kramvis A
    PLoS One; 2018; 13(5):e0196057. PubMed ID: 29718992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000.
    Yu L; Sloane DA; Guo C; Howell CD
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):355-60. PubMed ID: 16527700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis.
    Kennedy K; Graham SM; Arora N; Shuhart MC; Kim HN
    PLoS One; 2018; 13(9):e0204031. PubMed ID: 30252863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
    Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
    BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
    Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
    J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
    Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
    J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.
    Wang LY; You SL; Lu SN; Ho HC; Wu MH; Sun CA; Yang HI; Chien-Jen C
    Cancer Causes Control; 2003 Apr; 14(3):241-50. PubMed ID: 12814203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.
    Shire AM; Sandhu DS; Kaiya JK; Oseini AM; Yang JD; Chaiteerakij R; Mettler TA; Giama NH; Roberts RO; Therneau TM; Petersen GM; Knutson KL; Roberts LR
    Mayo Clin Proc; 2012 Jan; 87(1):17-24. PubMed ID: 22212964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.
    Mbaga DS; Kenmoe S; Kengne-Ndé C; Ebogo-Belobo JT; Mahamat G; Foe-Essomba JR; Amougou-Atsama M; Tchatchouang S; Nyebe I; Feudjio AF; Kame-Ngasse GI; Magoudjou-Pekam JN; Fokou LKM; Meta-Djomsi D; Maïdadi-Foudi M; Touangnou-Chamda SA; Daha-Tchoffo AG; Selly-Ngaloumo AA; Nayang-Mundo RA; Yéngué JF; Taya-Fokou JB; Kenfack-Momo R; Atembeh Noura E; Demeni Emoh CP; Tazokong HR; Bowo-Ngandji A; Sake CS; Atenguena Okobalemba E; Njiki Bikoi J; Njouom R; Riwom Essama SH
    PLoS One; 2022; 17(1):e0262903. PubMed ID: 35061846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.
    Yuan JM; Govindarajan S; Arakawa K; Yu MC
    Cancer; 2004 Sep; 101(5):1009-17. PubMed ID: 15329910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients.
    Cunha L; Carrilho C; Bhatt N; Loforte M; Maueia C; Fernandes F; Guisseve A; Mbofana F; Maibaze F; Mondlane L; Ismail M; Dimande L; Machatine S; Lunet N; Liu YT; Gudo ES; Pineau P
    Cancer Treat Res Commun; 2019; 19():100129. PubMed ID: 30903933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
    Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.